Sinopharm
1099.HK
#2259
Rank
โ‚น579.02 B
Marketcap
โ‚น185.54
Share price
0.70%
Change (1 day)
-22.04%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.087 T

According to Sinopharm's latest financial reports the company's current revenue (TTM) is โ‚น6.716 T. In 2022 the company made a revenue of โ‚น6.716 T a decrease over the revenue in the year 2021 that were of โ‚น6.860 T.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.087 T-24.25%
2022 โ‚น6.716 T-2.1%
2021โ‚น6.860 T16.85%
2020โ‚น5.870 T14.95%
2019โ‚น5.107 T21.52%
2018โ‚น4.202 T5.93%
2017โ‚น3.967 T27.22%
2016โ‚น3.118 T5.37%
2015โ‚น2.959 T9.14%
2014โ‚น2.711 T17.22%
2013โ‚น2.313 T25.94%
2012โ‚น1.836 T34.61%
2011โ‚น1.364 T55.34%
2010โ‚น878.39 B35.79%
2009โ‚น646.88 B37.56%
2008โ‚น470.26 B31.43%
2007โ‚น357.81 B40.26%
2006โ‚น255.10 B